CRESY Fundamental Analysis - CRESUD S.A.-SPONS ADR

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to CRESY. CRESY was compared to 86 industry peers in the Food Products industry. CRESY has a medium profitability rating, but doesn't score so well on its financial health evaluation. CRESY is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

Of the past 5 years CRESY 4 years were profitable.

Of the past 5 years CRESY 4 years had a positive operating cash flow.

1.2 Ratios

The Return On Assets of CRESY (2.06%) is comparable to the rest of the industry.

With a decent Return On Equity value of 10.78%, CRESY is doing good in the industry, outperforming 79.07% of the companies in the same industry.

Looking at the Return On Invested Capital, with a value of 2.40%, CRESY is in line with its industry, outperforming 47.67% of the companies in the same industry.

Measured over the past 3 years, the Average Return On Invested Capital for CRESY is significantly below the industry average of 28.69%.

		Industry Rank	Sector Rank
ROA	2.06%
ROE	10.78%
ROIC	2.4%

ROA(3y)2.76%

ROA(5y)1.46%

ROE(3y)14.12%

ROE(5y)0.78%

ROIC(3y)3.01%

ROIC(5y)2.17%

1.3 Margins

With an excellent Profit Margin value of 12.20%, CRESY belongs to the best of the industry, outperforming 93.02% of the companies in the same industry.

CRESY's Profit Margin has declined in the last couple of years.

CRESY's Operating Margin of 15.07% is amongst the best of the industry. CRESY outperforms 88.37% of its industry peers.

CRESY's Operating Margin has declined in the last couple of years.

CRESY has a better Gross Margin (38.46%) than 90.70% of its industry peers.

In the last couple of years the Gross Margin of CRESY has grown nicely.

		Industry Rank	Sector Rank
OM	15.07%
PM (TTM)	12.2%
GM	38.46%

OM growth 3Y42.09%

OM growth 5Y-1.83%

PM growth 3Y-35.22%

PM growth 5Y-2.22%

GM growth 3Y14.89%

GM growth 5Y2.1%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, CRESY has more shares outstanding

CRESY has more shares outstanding than it did 5 years ago.

The debt/assets ratio for CRESY is higher compared to a year ago.

2.2 Solvency

The Debt to FCF ratio of CRESY is 172.78, which is on the high side as it means it would take CRESY, 172.78 years of fcf income to pay off all of its debts.

CRESY's Debt to FCF ratio of 172.78 is in line compared to the rest of the industry. CRESY outperforms 47.67% of its industry peers.

A Debt/Equity ratio of 0.92 indicates that CRESY is somewhat dependend on debt financing.

CRESY has a worse Debt to Equity ratio (0.92) than 68.60% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.92
Debt/FCF	172.78
Altman-Z	N/A

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

CRESY has a Current Ratio of 1.24. This is a normal value and indicates that CRESY is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 1.24, CRESY is doing worse than 65.12% of the companies in the same industry.

CRESY has a Quick Ratio of 1.24. This is a bad value and indicates that CRESY is not financially healthy enough and could expect problems in meeting its short term obligations.

CRESY has a Quick ratio of 0.93. This is comparable to the rest of the industry: CRESY outperforms 56.98% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.24
Quick Ratio	0.93

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CRESY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.65%.

Measured over the past years, CRESY shows a very strong growth in Earnings Per Share. The EPS has been growing by 53.44% on average per year.

CRESY shows a small growth in Revenue. In the last year, the Revenue has grown by 5.23%.

The Revenue has been growing by 61.88% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)-35.65%

EPS 3Y8.92%

EPS 5Y53.44%

EPS Q2Q%25.74%

Revenue 1Y (TTM)5.23%

Revenue growth 3Y64.16%

Revenue growth 5Y61.88%

Sales Q2Q%-19.17%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

CRESY does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CRESUD S.A.-SPONS ADR

NASDAQ:CRESY (12/12/2025, 11:39:07 AM)

11.58

+0.02 (+0.17%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)11-10 2025-11-10

Earnings (Next)02-09 2026-02-09

Inst Owners5.97%

Inst Owner Change4.64%

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap725.50M

Revenue(TTM)857.48B

Net Income(TTM)104.60B

Analysts86.67

Price TargetN/A

Short Float %1.86%

Short Ratio2.66

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP83.59%

Div Incr Years2

Div Non Decr Years2

Ex-Date11-28 2025-11-28 (0.6240617)

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)N/A

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpSN/A

BVpSN/A

TBVpSN/A

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	2.06%
ROE	10.78%
ROCE	3.16%
ROIC	2.4%
ROICexc	2.72%
ROICexgc	2.74%
OM	15.07%
PM (TTM)	12.2%
GM	38.46%
FCFM	0.99%

ROA(3y)2.76%

ROA(5y)1.46%

ROE(3y)14.12%

ROE(5y)0.78%

ROIC(3y)3.01%

ROIC(5y)2.17%

ROICexc(3y)3.35%

ROICexc(5y)2.42%

ROICexgc(3y)3.42%

ROICexgc(5y)2.47%

ROCE(3y)3.97%

ROCE(5y)2.86%

ROICexgc growth 3Y35.18%

ROICexgc growth 5Y9.08%

ROICexc growth 3Y35.42%

ROICexc growth 5Y10.55%

OM growth 3Y42.09%

OM growth 5Y-1.83%

PM growth 3Y-35.22%

PM growth 5Y-2.22%

GM growth 3Y14.89%

GM growth 5Y2.1%

F-Score4

Asset Turnover0.17

Health

		Industry Rank	Sector Rank
Debt/Equity	0.92
Debt/FCF	172.78
Debt/EBITDA	6.16
Cap/Depr	298.6%
Cap/Sales	5.65%
Interest Coverage	1.45
Cash Conversion	39.16%
Profit Quality	8.1%
Current Ratio	1.24
Quick Ratio	0.93
Altman-Z	N/A

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)583.69%

Cap/Depr(5y)467.81%

Cap/Sales(3y)8.79%

Cap/Sales(5y)7.13%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-35.65%

EPS 3Y8.92%

EPS 5Y53.44%

EPS Q2Q%25.74%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)5.23%

Revenue growth 3Y64.16%

Revenue growth 5Y61.88%

Sales Q2Q%-19.17%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-36.36%

EBIT growth 3Y133.26%

EBIT growth 5Y58.92%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y127.06%

FCF growth 3Y-26.15%

FCF growth 5Y-36.69%

OCF growth 1Y15.68%

OCF growth 3Y23.9%

OCF growth 5Y-8.1%

CRESUD S.A.-SPONS ADR / CRESY FAQ

What is the fundamental rating for CRESY stock?

ChartMill assigns a fundamental rating of 3 / 10 to CRESY.

What is the valuation status for CRESY stock?

ChartMill assigns a valuation rating of 0 / 10 to CRESUD S.A.-SPONS ADR (CRESY). This can be considered as Overvalued.

How profitable is CRESUD S.A.-SPONS ADR (CRESY) stock?

CRESUD S.A.-SPONS ADR (CRESY) has a profitability rating of 5 / 10.

What is the financial health of CRESUD S.A.-SPONS ADR (CRESY) stock?

The financial health rating of CRESUD S.A.-SPONS ADR (CRESY) is 1 / 10.

CRESUD S.A.-SPONS ADR (CRESY) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

CRESUD S.A.-SPONS ADR / CRESY FAQ

What is the fundamental rating for CRESY stock?

What is the valuation status for CRESY stock?

How profitable is CRESUD S.A.-SPONS ADR (CRESY) stock?

What is the financial health of CRESUD S.A.-SPONS ADR (CRESY) stock?